Search Results

Filter
  • 1-10 of  625 results for ""ECULIZUMAB""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of Eculizumab Use in Renal Transplant Recipients.

  • Authors : Norville K; Department of Pharmacy, Mayo Clinic Hospital, Phoenix, AZ, USA.; Stephen J

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects ; Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/chemically induced

  • Source: Progress in transplantation (Aliso Viejo, Calif.) [Prog Transplant] 2023 Jun; Vol. 33 (2), pp. 162-167. Date of Electronic Publication: 2023 Mar 20.Publisher: Sage Country of Publication: United States NLM ID: 100909380 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature.

  • Authors : Fernandez-Ruiz R; Division of Rheumatology, New York University Grossman School of Medicine, New York, USA.; Blank RB

Subjects: Glomerulonephritis*/Glomerulonephritis*/Glomerulonephritis*/drug therapy ; Glomerulonephritis, Membranoproliferative* ; Kidney Diseases*

  • Source: Lupus [Lupus] 2021 Sep; Vol. 30 (10), pp. 1671-1678. Date of Electronic Publication: 2021 Jul 01.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Clinical Trials Portfolio for On-label and Off-label Studies of Eculizumab.

  • Authors : Kim MS; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland.; Prasad V

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/*drug therapy ; Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*drug therapy

  • Source: JAMA internal medicine [JAMA Intern Med] 2020 Feb 01; Vol. 180 (2), pp. 315-317.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

In Reply to 'Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy'.

Subjects: Glomerulonephritis, Membranoproliferative* ; Kidney Diseases*; Antibodies, Monoclonal, Humanized

  • Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2018 Dec; Vol. 72 (6), pp. 906-907. Date Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy.

Subjects: Glomerulonephritis, Membranoproliferative* ; Kidney Diseases*; Antibodies, Monoclonal, Humanized

  • Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2018 Dec; Vol. 72 (6), pp. 906. Date of Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Nephromegaly in an infant with atypical hemolytic-uremic syndrome resolving successfully with eculizumab.

  • Authors : Kumar G; Division of Pediatric Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/complications ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/complications

  • Source: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia [Saudi J Kidney Publisher: Medknow Country of Publication: Saudi Arabia NLM ID: 9436968 Publication Model: Print Cited Medium: Print ISSN: 1319-2442 (Print)

Record details

×
Academic Journal

Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities.

  • Authors : Antonucci L; Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.; Ph.D. Course in Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), University of Rome Tor Vergata, Rome, Italy.

Subjects: Glomerulonephritis, Membranoproliferative*/Glomerulonephritis, Membranoproliferative*/Glomerulonephritis, Membranoproliferative*/drug therapy ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/drug therapy

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 May; Vol. 39 (5), pp. 1387-1404. Date of Electronic Publication: 2023 Sep 21.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Eculizumab in neonatal hemolytic uremic syndrome with homozygous factor H deficiency.

  • Authors : Michaux K; Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, 59 boulevard Pinel Bron, 69677, Bron Cedex, France, .; Bacchetta J

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/*drug therapy ; Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/Atypical Hemolytic Uremic Syndrome/*etiology Complement Factor H Deficiency

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2014 Dec; Vol. 29 (12), pp. 2415-9. Date of Electronic Publication: 2014 Aug 23.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?

  • Authors : Saland J; Mount Sinai Medical School, 1 Gustave L. Levy Pl, New York, NY, 10029, USA, .

Subjects: Kidney Transplantation* ; Liver Transplantation* ; Mutation* Complement Factor H Deficiency

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2014 Mar; Vol. 29 (3), pp. 329-32. Date of Electronic Publication: 2013 Dec 22.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.

Subjects: Kidney Transplantation* ; Liver Transplantation* ; Mutation* Complement Factor H Deficiency

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2014 Mar; Vol. 29 (3), pp. 477-80. Date of Electronic Publication: 2013 Nov 13.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  625 results for ""ECULIZUMAB""